1. Home
  2. JOE vs DYN Comparison

JOE vs DYN Comparison

Compare JOE & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo St. Joe Company (The)

JOE

St. Joe Company (The)

N/A

Current Price

$67.37

Market Cap

3.4B

Sector

Real Estate

ML Signal

N/A

DYN

Dyne Therapeutics Inc.

N/A

Current Price

$16.53

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JOE
DYN
Founded
1936
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
JOE
DYN
Price
$67.37
$16.53
Analyst Decision
Strong Buy
Analyst Count
0
17
Target Price
N/A
$39.94
AVG Volume (30 Days)
182.7K
2.1M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
0.94%
N/A
EPS Growth
53.79
N/A
EPS
1.80
N/A
Revenue
$488,689,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$37.71
N/A
Revenue Growth
26.89
N/A
52 Week Low
$40.19
$6.36
52 Week High
$68.48
$25.00

Technical Indicators

Market Signals
Indicator
JOE
DYN
Relative Strength Index (RSI) 69.64 44.74
Support Level $64.42 $16.52
Resistance Level $67.35 $19.39
Average True Range (ATR) 1.60 0.98
MACD 0.19 0.03
Stochastic Oscillator 99.46 38.94

Price Performance

Historical Comparison
JOE
DYN

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: